Assurance® is a patient monitoring technology that enables the monitoring of multiple additional patient parameters beyond pulse oximetery, all from a comfortable and convenient single-point-of-contact sensor on the nasal ala (the fleshy side of the nose). The ultimate in patient comfort, Assurance® reduces false alarms associated with conventional finger pulse oximetery, and offers a faster response time for oxygen saturation, as well as enables the monitoring of respiration-related parameters.
|SMART® is a novel technology being developed to definitively monitor drug medication adherence in real-time. SMART® will enable pharmaceutical companies to know who is taking the medication and who is not. The system will enable real-time call-backs to the trial participants within a short time after they miss a dose. The anticipated benefits can directly impact the success of drug approval, and help to provide safer, more effective drug development. We intend to initially apply our SMART® technology in the clinical trial market.|
|Xhale's SMART Technology Showcased at Drug Development, Medication Adherence, and Innovation Meetings|
|Xhale Awarded NIH/NIMH SBIR Grant for Monitoring Microbicide Gel Use|
|Xhale Assurance Receives ISO 13485 Certification|
|Assurance® Alar One-Sense™ Pulse Oximetry Sensor to be Presented in Two Clinical Abstracts and an Educational Session at Society for Technology in Anesthesiology Meeting|